First Patient Enrolled in Lisinopril Calibration Study

Over the winter break, we enrolled our first patient into the calibration stage of the lisinopril in multiple sclerosis study. This initial stage of the trial is to validate the novel remote endpoint that we will use in the 100-patient, Phase 2 study. In designing this trial, we have adapted the Multiple Sclerosis Function Composite (MSFC) to be done from a patient's home or office via video chat. The examination consists of the participant completing a timed walk test, a dexterity peg test, and an mental arithmetic test. I've attached a couple photos to give you a sense of the telemedicine set up for this trial.

Article Type: 
Blog

Comments